TransEnterix to Ring Opening Bell at the New York Stock Exchange

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–July 07, 2014– TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use …

Read More

Transenterix, Inc. Prices Public Offering of Common Stock

Trading on NYSE MKT to Begin April 15, 2014 RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–April 14, 2014– TransEnterix, Inc. (NYSE MKT:TRXC), …

Read More

Abbott Completes Enrollment of Absorbâ„¢ Randomized Clinical Trials in the United States, Japan and China

First-of-its-Kind Dissolving Medical Device Being Evaluated in People with Blocked Heart Vessels Comprehensive Clinical Trial Program Demonstrates Abbott’s Global Leadership …

Read More